Each filer's latest filing for 09075V102 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Athos KG
13G/A
|
40.2% |
5/14/2026
Event 3/31/2026
|
||
| Athos KG | 40.2% | |||
| AT Impf GmbH | 40.2% | |||
| Thomas Maier | 40.2% | |||
|
Ugur Sahin
13G/A
|
15.8% |
5/15/2026
Event 3/31/2026
|
||
| Medine GmbH | 15.5% | |||
| Ugur Sahin | 15.8% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
|
Medine GmbH
13G/A
Amended
by Ugur Sahin
on 5/15/2026
|
17.6% |
5/13/2025
Event 3/31/2025
|
||
| Medine GmbH | 16.7% | |||
| Prof. Ugur Sahin, M.D. | 17.6% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 115 | 7.13 M | $701M |
| 2026 Q2 | 288 | 47.4 M | $4.82B |
| 2026 Q1 | 277 | 47.5 M | $4.22B |
| 2025 Q4 | 290 | 51.1 M | $4.86B |
| 2025 Q3 | 262 | 50.5 M | $4.98B |
| 2025 Q2 | 270 | 53.8 M | $5.73B |
| 2025 Q1 | 285 | 51.8 M | $4.72B |
| 2024 Q4 | 311 | 50.9 M | $5.80B |
| 2024 Q3 | 305 | 44.3 M | $5.25B |
| 2024 Q2 | 289 | 42.3 M | $3.40B |
| 2024 Q1 | 292 | 43.1 M | $3.98B |
| 2023 Q4 | 289 | 41.6 M | $4.38B |
| 2023 Q3 | 260 | 37.0 M | $4.02B |
| 2023 Q2 | 263 | 37.5 M | $4.05B |
| 2023 Q1 | 290 | 41.0 M | $4.92B |
| 2022 Q4 | 326 | 39.9 M | $6.04B |
| 2022 Q3 | 271 | 37.2 M | $5.02B |
| 2022 Q2 | 301 | 33.5 M | $4.99B |
| 2022 Q1 | 294 | 34.7 M | $5.91B |
| 2021 Q4 | 363 | 36.3 M | $9.22B |
| 2021 Q3 | 343 | 36.7 M | $10.0B |
| 2021 Q2 | 290 | 34.9 M | $7.84B |
| 2021 Q1 | 229 | 29.9 M | $3.26B |
| 2020 Q4 | 201 | 22.4 M | $1.83B |
| 2020 Q3 | 152 | 24.4 M | $1.69B |
| 2020 Q2 | 111 | 26.7 M | $1.78B |
| 2020 Q1 | 38 | 6.62 M | $384M |
| 2019 Q4 | 20 | 8.48 M | $286M |